How often should sitting and rising from a chair be evaluated in patients with Duchenne muscular dystrophy?

被引:0
|
作者
Hukuda, Michele Emy [1 ]
Caromano, Fatima Aparecida [1 ]
Escorcio, Renato [1 ]
de Carvalho, Eduardo Vital [1 ]
Blascovi-Assist, Silvana Maria [2 ]
Voos, Mariana Callil [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Lab Fisiote & Comportamento, Sao Paulo, SP, Brazil
[2] Univ Mackenzie, Fac Fisiote, Sao Paulo, SP, Brazil
关键词
muscular dystrophy; Duchenne; motor activity; task performance and analysis; outcome assessment (health care); physical examination; MOTOR FUNCTION MEASURE; HEALTH-STATUS MEASURES; EVALUATION SCALE; RESPONSIVENESS; CHILDREN; AMBULATION; INDEX;
D O I
10.1590/0004-282X20170101
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: To determine how often sitting/rising from a chair should be assessed in Duchenne muscular dystrophy (DMD) patients to avoid redundant/missing data. Methods: Sitting/rising from a chair was evaluated in 26 DMD children (5-12 yrs), in three-month intervals, over twelve months, with the Functional Evaluation Scale (domain sitting/rising from a chair). Scores were compared by effect sizes (ES) and standardized response means (SRM) (responsiveness analysis). Results: Sit-to-stand showed low -to-moderate responsiveness in three-month intervals (ES:0.23-0.32; SRM:0.36-0.68), moderate-to-high responsiveness in six-month intervals (ES:0.52-0.65; SRM:0.76-1.28), high responsiveness at nine-month (ES:0.84-0.91; SRM:1.26-1.64) and twelve-month intervals (ES:1.27; SRM:1.48). Stand-to-sit showed low responsiveness in three-month intervals (ES:0.26-0.49; SRM:0.37-0.42), moderate responsiveness in six-month intervals (ES:0.50-0.78; SRM:0.56-0.71), high responsiveness in nine-month (ES:0.94-1.00; SRM:0.84-1.02) and twelve-month intervals (ES:1.13; SRM:1.52). Conclusion: Six months or longer intervals for reassessment are indicated to evaluate sitting/standing from a chair in DMD patients.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 50 条
  • [31] Autonomic function in patients with Duchenne muscular dystrophy
    Inoue, Miki
    Mori, Kazuhiro
    Hayabuchi, Yasunobu
    Tatara, Katsunori
    Kagami, Shoji
    PEDIATRICS INTERNATIONAL, 2009, 51 (01) : 33 - 40
  • [32] Body composition of patients with Duchenne muscular dystrophy
    Wong, B.
    Hu, S.
    Horn, P.
    Rybalsky, I.
    Shellenbarger, K.
    Tian, C.
    Bange, J.
    Kalkwarf, H.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S103 - S103
  • [33] A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy
    Bylo, Mary
    Farewell, Raechel
    Coppenrath, Valerie A.
    Yogaratnam, Dinesh
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 788 - 794
  • [34] OSTEOPOROSIS IN ADULT PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
    Keen, Richard
    Bubbear, Juddith
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : 648 - 649
  • [35] Cognition of the mothers of patients with Duchenne muscular dystrophy
    Demirci, Hasan
    Durmus, Hacer
    Toksoy, Guven
    Uslu, Atilla
    Parman, Yesim
    Hanagasi, Hasmet
    MUSCLE & NERVE, 2020, 62 (06) : 710 - 716
  • [36] Quality of sleep of Duchenne muscular dystrophy patients
    Tarozo, K. A.
    Godoy, T. S.
    Godoy, A. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S300 - S301
  • [37] Anaesthetic management in patients with Duchenne muscular dystrophy
    Errando, Carlos L.
    Perez-Caballero, Paula
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2013, 30 (05) : 257 - 257
  • [38] Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy
    Lo Cascio, Christian M.
    Goetze, Oliver
    Latshang, Tsogyal D.
    Bluemel, Sena
    Frauenfelder, Thomas
    Bloch, Konrad E.
    PLOS ONE, 2016, 11 (10):
  • [39] Cell therapy for patients with Duchenne muscular dystrophy
    Davis, Darryl R.
    LANCET, 2022, 399 (10329): : 1024 - 1025
  • [40] Specific features of Becker Muscular Dystrophy patients and female carriers of Duchenne Muscular Dystrophy
    Magot, A.
    Mercier, S.
    Pereon, Y.
    ARCHIVES DE PEDIATRIE, 2015, 22 : S31 - S36